Table 2.
Presenting features
| Characteristic | N (%) |
|---|---|
| Age at on study, y | |
| 0-4 | 2 (2) |
| 5-9 | 8 (8) |
| 10-14 | 41 (42) |
| 15+ | 47 (48) |
| Sex | |
| Male | 49 (50) |
| Female | 49 (50) |
| Race | |
| White | 67 (68) |
| Hispanic | 12 (12) |
| Black | 9 (9) |
| Other | 7 (7) |
| Not reported | 3 (3) |
| Clinical stage | |
| II | 23 (23) |
| III | 17 (17) |
| IV | 58 (59) |
| Hodgkin lymphoma subtype | |
| Nodular sclerosis, classic | 86 (87) |
| Mixed cellularity, classic | 7 (7) |
| Nodular lymphocyte predominant | 3 (3) |
| Lymphocyte-rich, classic | 1 (1) |
| Not classifiable into one of the above | 1 (1) |
| Presence of B symptoms | |
| No | 28 (29) |
| Yes | 69 (70) |
| Not reported | 1 (1) |
| Hilar adenopathy | |
| No | 24 (24) |
| Yes | 72 (73) |
| Not reported | 2 (2) |
| Node/aggregate > 10 cm | |
| No | 60 (61) |
| Yes | 33 (34) |
| No. of nodal regions | |
| 1 | 6 (6) |
| 2 | 20 (20) |
| 3 | 23 (23) |
| 4 | 13 (13) |
| 5+ | 36 (37) |
| Anterior mediastinal mass | |
| No | 14 (14) |
| Yes < one-third diameter | 29 (30) |
| Yes > one-third diameter | 51 (52) |
| Not reported | 4 (4) |
| Bulk disease | |
| No | 33 (34) |
| Yes | 62 (63) |
| Not reported | 3 (3) |